BTK and systemic lupus erythematosus: Clinical trials are currently underway to investigate the effect of BTK inhibition in autoimmune diseases including RA, SLE, pemphigus, Sjögren’s syndrome, and multiple sclerosis (www.clinicaltrials.gov, accessed on 12 May 2021).